These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 33317572)
1. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer. Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572 [TBL] [Abstract][Full Text] [Related]
2. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer. Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424 [TBL] [Abstract][Full Text] [Related]
3. MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway. Zhao S; Cheng L; Shi Y; Li J; Yun Q; Yang H Cell Death Dis; 2021 Jan; 12(1):18. PubMed ID: 33414447 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer. Wang Y; Li J; Xu C; Zhang X Oncol Res; 2018 Apr; 26(3):411-420. PubMed ID: 28653604 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of MiD49 contributes to tumor growth and metastasis of human pancreatic cancer. Bai L; Liang J; Li L; Li E Oncol Rep; 2020 Apr; 43(4):1208-1220. PubMed ID: 32323835 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation. Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776 [TBL] [Abstract][Full Text] [Related]
7. An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications. Dasgupta A; Chen KH; Wu D; Hoskin V; Mewburn J; Lima PDA; Parlow LRG; Hindmarch CCT; Martin A; Sykes EA; Tayade C; Lightbody ED; Madarnas Y; SenGupta SK; Elliott BE; Nicol CJB; Archer SL FASEB J; 2020 Apr; 34(4):5106-5127. PubMed ID: 32068312 [TBL] [Abstract][Full Text] [Related]
8. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer. Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1. Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890 [TBL] [Abstract][Full Text] [Related]
10. miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism. Muys BR; Sousa JF; Plaça JR; de Araújo LF; Sarshad AA; Anastasakis DG; Wang X; Li XL; de Molfetta GA; Ramão A; Lal A; Vidal DO; Hafner M; Silva WA Cancer Res; 2019 Jul; 79(13):3294-3305. PubMed ID: 31101765 [TBL] [Abstract][Full Text] [Related]
11. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival. Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220 [TBL] [Abstract][Full Text] [Related]
13. MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1. Xu Y; Zhao S; Shen Y; Li Y; Dang Y; Guo F; Chen Z; Li J; Yang H Apoptosis; 2024 Aug; 29(7-8):1232-1245. PubMed ID: 38615083 [TBL] [Abstract][Full Text] [Related]
14. A FXYD5/TGF‑β/SMAD positive feedback loop drives epithelial‑to‑mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer. Bai Y; Li LD; Li J; Chen RF; Yu HL; Sun HF; Wang JY; Lu X Int J Oncol; 2020 Jan; 56(1):301-314. PubMed ID: 31746425 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1. Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838 [TBL] [Abstract][Full Text] [Related]
16. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma. Zhu X; Du J; Gu Z Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775 [TBL] [Abstract][Full Text] [Related]
17. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
18. Lost miR-141 and upregulated TM4SF1 expressions associate with poor prognosis of pancreatic cancer: regulation of EMT and angiogenesis by miR-141 and TM4SF1 via AKT. Xu D; Yang F; Wu K; Xu X; Zeng K; An Y; Xu F; Xun J; Lv X; Zhang X; Yang X; Xu L Cancer Biol Ther; 2020 Apr; 21(4):354-363. PubMed ID: 31906774 [No Abstract] [Full Text] [Related]
19. SLC45A4 is involved in malignant progression of ovarian cancer through glycolytic metabolic reprogramming. Xu Y; Han X; You S; Zhu W; Zhang M; Lu C; He J; Yao Q Sci Rep; 2024 Oct; 14(1):23031. PubMed ID: 39363015 [TBL] [Abstract][Full Text] [Related]
20. The mitochondrial elongation factors MIEF1 and MIEF2 exert partially distinct functions in mitochondrial dynamics. Liu T; Yu R; Jin SB; Han L; Lendahl U; Zhao J; Nistér M Exp Cell Res; 2013 Nov; 319(18):2893-904. PubMed ID: 23880462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]